CIAM
IART icon

Caitong International Asset Management’s Integra LifeSciences IART Stock Holding History

Caitong International Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.68K Buy
205
+147
+253% +$2.06K ﹤0.01% 1324
2026
Q1 		$546 Buy
+58
New +$637 ﹤0.01% 1619
2025
Q4 		– Sell
-497
Closed -$7.12K – 2100
2025
Q3 		$7.12K Sell
497
-2,635
-84% -$36.1K ﹤0.01% 1119
2025
Q2 		$38.4K Buy
3,132
+2,108
+206% +$30.6K 0.03% 328
2025
Q1 		$22.5K Buy
1,024
+98
+11% +$2.3K 0.02% 719
2024
Q4 		$21K Buy
+926
New +$20.2K 0.02% 777

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Caitong International Asset Management's IART Position: Q2 2026 in Review

Caitong International Asset Management increased its Integra LifeSciences (IART) stake by 253% in Q2 2026, buying an estimated $2.06K and bringing the position to 205 shares worth $3.68K. The position accounts for ﹤0.01% of the portfolio, ranked #1324.

Caitong International Asset Management first reported a position in IART in Q4 2024 and has held it in 6 quarters since. The position peaked at $38.4K in Q2 2025. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Caitong International Asset Management held 205 shares of Integra LifeSciences worth $3.68K as of Q2 2026.
  • Caitong International Asset Management bought 147 Integra LifeSciences shares in Q2 2026, an estimated $2.06K.
  • Integra LifeSciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1324 holding.
  • Caitong International Asset Management first reported a position in Integra LifeSciences in Q4 2024 and has held it in 6 quarters since.
  • Caitong International Asset Management's Integra LifeSciences position peaked at $38.4K in Q2 2025.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.